Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE) (vol 37, pg 2687, 2019)

被引:0
|
作者
Sando, Eiichiro [1 ,2 ,3 ]
Suzuki, Motoi [1 ]
Furumoto, Akitsugu [4 ]
Asoh, Norichika [5 ]
Yaegashi, Makito [3 ]
Aoshima, Masahiro [6 ]
Ishida, Masayuki [7 ]
Hamaguchi, Sugihiro [8 ]
Otsuka, Yoshihito [9 ]
Morimoto, Konosuke [1 ,2 ]
机构
[1] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Sakamoto 1-12-4, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Trop Med, Nagasaki, Japan
[3] Kameda Med Ctr, Dept Gen Internal Med, Chiba, Japan
[4] Nagasaki Rosai Hosp, Dept Infect Dis, Nagasaki, Japan
[5] Juzenkai Hosp, Dept Internal Med, Nagasaki, Japan
[6] Kameda Med Ctr, Dept Pulmonol, Chiba, Japan
[7] Chikamori Hosp, Dept Resp Med, Kochi, Japan
[8] Fukushima Med Univ, Dept Gen Internal Med, Fukushima, Japan
[9] Kameda Med Ctr, Dept Lab Med, Chiba, Japan
关键词
D O I
10.1016/j.vaccine.2020.03.031
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:3404 / 3404
页数:1
相关论文
共 50 条
  • [1] Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)
    Sando, Eiichiro
    Suzuki, Motoi
    Furumoto, Akitsugu
    Asoh, Norichika
    Yaegashi, Makito
    Aoshima, Masahiro
    Ishida, Masayuki
    Hamaguchi, Sugihiro
    Otsuka, Yoshihito
    Morimoto, Konosuke
    [J]. VACCINE, 2019, 37 (20) : 2687 - 2693
  • [2] Impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia and pneumococcal pneumonia in children in Japan
    Ishiwada, Naruhiko
    Naito, Sachiko
    Takeuchi, Noriko
    Ohkusu, Misako
    Nagasawa, Koo
    Abe, Katsuaki
    Omata, Yuko
    Hishiki, Haruka
    Hoshino, Tadashi
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S46 - S46
  • [3] Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019
    Tamura, Kosuke
    Chang, Bin
    Shimbashi, Reiko
    Watanabe, Hiroshi
    Tanabe, Yoshinari
    Kuronuma, Koji
    Oshima, Kengo
    Maruyama, Takaya
    Fujita, Jiro
    Abe, Shuichi
    Kasahara, Kei
    Nishi, Junichiro
    Kubota, Tetsuya
    Kinjo, Yuki
    Fujikura, Hiroyuki
    Fukusumi, Munehisa
    Shimada, Tomoe
    Sunagawa, Tomimasa
    Suzuki, Motoi
    Yamamoto, Yoshihiro
    Oishi, Kazunori
    [J]. VACCINE, 2022, 40 (24) : 3338 - 3344
  • [4] Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness
    Tam, Pui-Ying Iroh
    Hanisch, Benjamin R.
    Forward, Brennan
    [J]. CLINICAL PEDIATRICS, 2015, 54 (06) : 591 - 593
  • [5] Pneumococcal meningitis in adults in 2014–2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Bin Chang
    Kosuke Tamura
    Hiroyuki Fujikura
    Hiroshi Watanabe
    Yoshinari Tanabe
    Koji Kuronuma
    Jiro Fujita
    Kengo Oshima
    Takaya Maruyama
    Shuichi Abe
    Kei Kasahara
    Junichiro Nishi
    Tetsuya Kubota
    Yuki Kinjo
    Yusuke Serizawa
    Reiko Shimbashi
    Munehisa Fukusumi
    Tomoe Shimada
    Tomimasa Sunagawa
    Motoi Suzuki
    Kazunori Oishi
    [J]. Scientific Reports, 12
  • [6] Clinical and Bacteriological Analysis of Pediatric Pneumococcal Meningitis after 13-Valent Pneumococcal Conjugate Vaccine Introduction in Japan
    Kurihara, Erika
    Takeshita, Kenichi
    Tanaka, Saori
    Takeuchi, Noriko
    Ohkusu, Misako
    Hishiki, Haruka
    Ishiwada, Naruhiko
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [7] The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study
    van Deursen, Anna M. M.
    van Houten, Marlies A.
    Webber, Chris
    Patton, Michael
    Scott, Daniel
    Patterson, Scott
    Jiang, Qin
    Gruber, William C.
    Schmoele-Thoma, Beate
    Grobbee, Diederick E.
    Beaten, Marc J. M.
    Sanders, Elisabeth A. M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 67 (01) : 42 - 49
  • [8] Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan
    Chang, Bin
    Tamura, Kosuke
    Fujikura, Hiroyuki
    Watanabe, Hiroshi
    Tanabe, Yoshinari
    Kuronuma, Koji
    Fujita, Jiro
    Oshima, Kengo
    Maruyama, Takaya
    Abe, Shuichi
    Kasahara, Kei
    Nishi, Junichiro
    Kubota, Tetsuya
    Kinjo, Yuki
    Serizawa, Yusuke
    Shimbashi, Reiko
    Fukusumi, Munehisa
    Shimada, Tomoe
    Sunagawa, Tomimasa
    Suzuki, Motoi
    Oishi, Kazunori
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01) : 3066
  • [9] Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
    Rodrigo, Chamira
    Bewick, Thomas
    Sheppard, Carmen
    Greenwood, Sonia
    Mckeever, Tricia M.
    Trotter, Caroline L.
    Slack, Mary
    George, Robert
    Lim, Wei Shen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1632 - 1641
  • [10] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A414 - A414